©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jun 27, 2021; 13(6): 650-661
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.650
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.650
Balloon-occluded retrograde transvenous obliteration for treatment of gastric varices
Nobuo Waguri, Akihiko Osaki, Yusuke Watanabe, Department of Gastroenterology and Hepatology, Niigata City General Hospital, Niigata 950-1197, Japan
Author contributions: Waguri N wrote the manuscript; Osaki A drew the illustrations; Watanabe Y reviewed the paper.
Conflict-of-interest statement: There are no conflicts of interest.
Corresponding author: Nobuo Waguri, MD, PhD, Chief Doctor, Director, Department of Gastroenterology and Hepatology, Niigata City General Hospital, 467-3 Shumoku, Chuo-ku, Niigata 950-1197, Japan. waguri@hosp.niigata.niigata.jp
Received: February 25, 2021
Peer-review started: February 25, 2021
First decision: March 29, 2021
Revised: April 12, 2021
Accepted: May 22, 2021
Article in press: May 22, 2021
Published online: June 27, 2021
Processing time: 117 Days and 20.5 Hours
Peer-review started: February 25, 2021
First decision: March 29, 2021
Revised: April 12, 2021
Accepted: May 22, 2021
Article in press: May 22, 2021
Published online: June 27, 2021
Processing time: 117 Days and 20.5 Hours
Core Tip
Core Tip: Gastric varices (GVs) are a common complication of liver cirrhosis and their rupture is often fatal. Balloon-occluded retrograde transvenous obliteration (BRTO) has been widely adopted for treatment of GVs because of its effectiveness, ability to cure, and utility in emergency and prophylactic treatment. Various modifications of BRTO and combinations with other therapies are also beneficial. Combined BRTO and partial splenic embolization shows promise as a treatment option.